多学科血管实践的结果:慢性肢体威胁性缺血患者12个月无截肢生存及更长期结局
该回顾性研究评估了2015至2021年间在本多学科血管实践(介入放射科与血管外科医生,在办公室介入套房、门诊手术中心和医院住院/门诊环境下治疗)中接受治疗的829条肢体(Rutherford 4-6级)的结局。1年死亡率为6.2%,大截肢率为2.3%,1年无截肢生存率为91.5%,平均随访22.3个月。作者认为多学科手术与血管内治疗可能为患者提供最佳的无截肢生存机会。
要点
- 829条慢性肢体威胁性缺血肢体中,63.5%需多平面干预,541例有至少1个慢性完全闭塞。
- 1年死亡率为6.2%,大截肢率为2.3%,1年无截肢生存率为91.5%。
- 1年无临床驱动靶病变血运重建率为78.7%,12个月内重复干预163例。
核心结论
- 多学科手术与血管内治疗可能为患者提供最佳的无截肢生存机会。
研究设计与样本
- 回顾性综述,纳入2015至2021年在本实践接受治疗的Rutherford 4、5、6级患者,共829条肢体(351例女性,478例男性)。
主要发现
- 829条肢体中541例有至少1个慢性完全闭塞,其中115条肢体有2个慢性完全闭塞,24条肢体有3个慢性完全闭塞,63.5%的病例需要多平面干预。
- 1年死亡率为6.2%,大截肢率为2.3%,平均随访22.3个月。
- 1年无临床驱动靶病变血运重建率为78.7%,12个月内重复干预163例。
- 在股腘动脉支架亚组中,使用较新支架技术(如编织镍钛合金和药物洗脱技术)时,再干预时间显著延长(p=0.03)。
- 总体1年无截肢生存率为91.5%。
临床怎么用
- 作者认为,基于密切常规随访和动脉双功超声监测的强临床实践,以及使用药物洗脱支架和药物涂层球囊等最新技术,是获得最佳患者结局的主要促进因素。
- 作者希望本研究为其他实践提供建立或修改其实践以获取最佳手术和临床结局的指南。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is great variability in the treatment of chronic limb-threatening ischemia, including the practice paradigm, vascular provider specialty, devices utilized, and experience with advanced open and/or endovascular treatments, among other factors. Our unique practice consists of patient-centered, clinically oriented Interventional Radiologists and Vascular Surgeons, with treatments being performed in Office Interventional Suites (OIS), Ambulatory surgery center (ASC), and hospital inpatient/outpatient settings. We evaluate our results, centered on major amputation rates while comparing case complexity and rates with previously published data. METHODS: A retrospective review was performed of all Rutherford 4, 5, and 6 patients who underwent treatment in our practice from 2015 to 2021. Baseline patient characteristics, complexity of lesions, and major amputation rates were collected. Patients with more complex diseases or requiring re-interventions were openly discussed in multidisciplinary fashion to determine the group's approach to revascularization. Limb salvage, clinically driven target lesion revascularization (TLR), repeat interventions, length of follow-up, and mortality were assessed. RESULTS: Treatment was performed in 829 limbs in 351 females and 478 males, with chronic limb-threatening ischemia. Of the 829 cases, 541 cases had at least 1 chronic total occlusion (CTO), including 115 limbs with 2 CTOs and 24 limbs with 3 CTOs with 63.5% of cases requiring multilevel intervention. One year mortality rate was 6.2% with a major lower extremity amputation rate of 2.3% with a mean length of follow-up of 22.3 months. One-year freedom from clinically driven TLR rate was 78.7% with repeat intervention in 163 cases within 12 months. Over the course of the study, within the femoropopliteal stent subset, there was a significant increase in time to reintervention when newer stent technologies were utilized such as woven nitinol and drug-eluting technology (p=0.03). The overall 1-year amputation-free survival (AFS) was 91.5%Conclusions:Multidisciplinary approach with surgical and endovascular treatment may provide patients with the best chance of AFS.Clinical ImpactReal world practice of critical limb-threatening ischemia in a multidisciplinary practice demonstrates favorable outcomes for patients with the best reported one year major amputation free survival in a population this large. A strong clinical practice based on close routine follow up and arterial duplex monitoring is a major contributing factor, as well as utilization of the latest technology in drug eluting stents and drug coated balloons for best patient outcomes. We hope this study provides other practices with a guideline for establishing or modifying their practice to attain the best procedural and clinical outcomes.
引用
- Patel RA, Fallon B, Brandis A, et al. Outcomes of a Multidisciplinary Vascular Practice: 12-Month Amputation-Free Survival and Beyond in Patients With Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2024. PMID: 39234958. doi:10.1177/15266028241276328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。